128. Betta agonists: What is the
evidence that their use increases
the risk of asthma morbidity and mortality? / R. Beasley, N. Pearce, J. Crane,
C. Burgess // J. Allergy Clin. Immunol. - 1999. - Vol. 104, № 2. - P. 197 -
202
.
129. Blumenthal J.B. Genetics of asthma / J.B. Blumenthal, M.N. Blumenthal //
Med.Clin. Noth Am. - 2002. - Vol.
86
, № 5. - P. 937 - 950.
130. Charpin J. Perspectives d’avenir de la desensibilisation specifique / J. Char-
pin, D. Vervloet. // Bull. Acad. mat. med. - 1978. - Vol. 162, № 2. - P. 176 -
180.
131. Court C.S. Comparative epidemiology of atopic and non-atopic wheeze
and diagnosed asthma in a national sample of English adults / C.S. Court,
D.G. Cook, D.P. Strachan. // Thorax. - 2002. - Vol. 57, № 11. - P. 951 -
957.
132. Daniel E.E. Effect of inflammatory mediators on airway nerves and muscles /
E.E. Daniel, P. Byrke. // Amer. Rev. resp. Dis. - 1991. - Vol. 143, № 3. - Part
2, P. 35 - 36.
133. Determination of beta-2-adrenergic receptor (ADRB2) halotypes by a multi
plexed polymerase chain reaction assay / M.D. Littlejohn, D.R. Taylor, A.L.
Miller, M.A. Kennedy // Hum. Mutat. - 2002. - Vol. 20, №
6
. - P. 479 - 480.
134. Development and validation of the Mini Asthma Quality of Life Question
naire / E.F. Juniper, G.H. Guyatt, F.M. Cox et al. // Eur. Respir. J. - 1999. - №
14. - P. 32 -38.
135. Development and validation of a questionnaire to measure asthma control /
E.F. Juniper, P.M. O’Byme, G.H. Guyatt et al. // Eur. Respir. J. - 1999. - №
14. - P. 902 -907.
136. Differential regulation by glucocorticoid of interleukin-13-induced eosino-
philia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways / A.
Kube, H. Inoue, S. Fukuyama et al. // Am. J. Respir. Crit. Care Med. - 2003. -
Vol. 167, № l . - P . 50- 56.
139
